Research and Markets (http://www.researchandmarkets.com/research/wphfq7/nasopharyngeal) has announced the addition of the "Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014" report to their offering.
Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Nasopharyngeal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nasopharyngeal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nasopharyngeal Cancer.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Clinical Trial Overview of Top Companies/Organisations
- Sanofi
- F. Hoffmann-La Roche Ltd.
- Merck & Co., Inc.
- Jiangsu Hengrui Medicine Co., Ltd.
- ZonMw
- Roche Hong Kong Limited
- Lakewood-Amedex Inc.
- C. H. Boehringer Sohn AG & Co. KG
- Biotech Pharmaceuticals Co., Ltd.
- National Cancer Institute
- Sun Yat-sen University
- Sun Yat-Sen University Cancer Center
- Chinese University of Hong Kong
- FUDAN University
- Baylor College of Medicine
- National University Hospital
- European Organization for Research and Treatment of Cancer
- The University of Hong Kong
- University of Washington
For more information visit http://www.researchandmarkets.com/research/wphfq7/nasopharyngeal
Contacts:
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology
